General Biologicals Corporation (TPEX:4117)
10.20
-0.10 (-0.97%)
Aug 19, 2026, 1:20 PM CST
-35.24% (1Y)
| Market Cap | 757.83M -21.4% |
| Revenue (ttm) | 260.23M +3.5% |
| Net Income | 518.98M |
| EPS | 7.67 |
| Shares Out | 70.83M |
| PE Ratio | 1.40 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 61,233 |
| Open | 9.96 |
| Previous Close | 10.30 |
| Day's Range | 9.90 - 10.40 |
| 52-Week Range | 3.50 - 17.85 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 20, 2026 |